Jennifer McMahon is a Partner at Seroba.  She graduated from UCD with an honours degree in Pharmacology in 2010.  Jennifer then entered a Master’s degree programme in Biotechnology and Business to further her interest in the interface of biomedical science with commercialisation.

Having placed first in her Master’s degree in 2011, Jennifer then joined Seroba’s Investment Team as an Investment Analyst, progressing to Partner in 2022.

In 2019, Jennifer joined the Advisory Board for the European healthcare Businesswomen’s Association.  She is Chair of Level20 Europe and was a founder member of the Ireland Chapter of Level20.  She guest lectures on venture capital at University College Dublin, Trinity College Dublin and the Royal College of Surgeons in Ireland.  She is also in high demand as a speaker at Investor/Entrepreneur life science partnering conferences across Europe.

Jennifer sits on the boards of Endotronix, Palliare and Deciphex, is a Board Observer to Shorla Pharma and was previously on the Board of Biosensia prior to its merger with Kypha Diagnostics.